| abstract |
Novel pharmaceutical compositions are provided, in particular oral formulations for once a day administration of a drug/medicament and to novel solid dose units for incorporation therein are provided. The solid dose units provide a phased release of drug to target or prolong the pharmaceutical effect. The compositions are particularly useful for multiphase delivery of proton pump inhibitors such as lansoprazole, pantoprazole, omeprazole, perprazole, etc. |